Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Asset disposition
Director departure
|
|
ENZON PHARMACEUTICALS, INC. (ENZN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/14/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/17/2020 |
SC 13D/A
| COUCHMAN JONATHAN reports a 17.8% stake in Enzon Pharmaceuticals, Inc. |
| 09/01/2020 |
SC 13D/A
| ICAHN CARL C has filed a Schedule 13D for Enzon Pharmaceuticals, Inc. |
| 08/07/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/05/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/08/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/29/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/09/2013 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/28/2012 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 08/22/2011 |
SC 13D/A
| ENZON PHARMACEUTICALS INC reports a 12.3% stake in Enzon Pharmaceuticals, Inc |
| 08/15/2011 |
SC 13D/A
| ENZON PHARMACEUTICALS INC reports a 12.3% stake in Enzon Pharmaceuticals, Inc |
| 03/04/2011 |
SC 13D/A
| ENZON PHARMACEUTICALS INC reports a 4.8% stake in Enzon Pharmaceuticals, Inc. |
| 11/18/2010 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 11/16/2010 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 05/18/2010 |
SC 13D/A
| DellaCamera Capital Management, LLC reports a 5.9% stake in Enzon Pharmaceuticals, Inc. |
| 04/05/2010 |
SC 13D/A
| Iridian Asset Management reports a 11.2% stake in Enzon Pharmaceuticals, Inc |
| 02/22/2010 |
SC 13D/A
| DellaCamera Capital Management, LLC reports a 8% stake in Enzon Pharmaceuticals, Inc. |
| 01/11/2010 |
SC 13D/A
| Iridian Asset Management reports a 15.4% stake in Enzon Pharmaceuticals, Inc |
| 12/14/2009 |
SC 13D/A
| DellaCamera Capital Management, LLC reports a 8.1% stake in Enzon Pharmaceuticals, Inc. |
| 07/27/2009 |
SC 13D/A
| DellaCamera Capital Management, LLC reports a 8.3% stake in Enzon Pharmaceuticals, Inc. |
| 04/22/2009 |
SC 13D/A
| Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend] |
| 03/20/2009 |
SC 13D/A
| Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend] |
| 01/29/2009 |
SC 13D/A
| Carl Icahn reports a 7.8% stake in Enzon Pharmaceuticals, Inc. |
| 01/28/2009 |
SC 13D/A
| DellaCamera Capital Management, LLC reports a 7.6% stake in Enzon Pharmaceuticals, Inc. |
| 01/07/2009 |
SC 13D/A
| DellaCamera Capital Management, LLC reports a 7.6% stake in Enzon Pharmaceuticals, Inc. |
|
|